发明名称 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
摘要 The invention relates to compounds of the formula (I), where the symbols have the meaning given in the specification, for use in a method for treating cancer, to use of these compounds for the manufacture of a pharmaceutical composition for the treatment of cancer, and to methods of treatment for said diseases employing a compound of formula (I).;
申请公布号 US9108941(B2) 申请公布日期 2015.08.18
申请号 US200913141231 申请日期 2009.12.22
申请人 DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS 发明人 Kraemer Alwin;Leber Blanka;Clausen Mads;Larsen Thomas;Roennest Mads;Worm Kasper
分类号 C07D307/94;A61K31/343;C07D405/12;C07D407/12 主分类号 C07D307/94
代理机构 Clark & Elbing LLP 代理人 Clark & Elbing LLP ;Bieker-Brady Kristina
主权项 1. A compound of the formula (I) wherein the symbols in formula (I) have the following meanings: A is ═O, X is Cl, Y is —O—, Z is —(CH2)n—, n is 0 or 1, R2 is hydrogen or halogen, R1 is, in case R2 is hydrogen and n is other than 0: phenyl or pyridyl, wherein the phenyl, or pyridyl group is substituted on one or more ring carbon atoms by identical or different substituents R10, R1 is, in case R2 is hydrogen and n is 0: phenyl, wherein the phenyl group is substituted on one or more ring carbon atoms by identical or different substituents R10, R1 is, in case R2 is halogen: linear or branched (C1-C10)-alkyl, R10 is halogen, nitro, linear or branched (C1-C10)-alkyl, phenyl hydroxyl-(C1-C4)-alkyl, or halogen-(C1-C4)-alkyl, R3 is methyl, R4 is methyl,and/or a pharmaceutically acceptable salt thereof.
地址 Heidelberg DE
您可能感兴趣的专利